1 / 4

Global Allergy Immunotherapy Market Industry Size, Share, Growth and Forecast To 2025

Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report by Type (Allergic Rhinitis, AllergicAsthma, Food Allergy, Drug Allergy, and Others), by Treatment (Subcutaneous Immunotherapy, Sublingual Immunotherapy), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Forecast 2019-2025<br>

rishabh3210
Télécharger la présentation

Global Allergy Immunotherapy Market Industry Size, Share, Growth and Forecast To 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Orion Market Research Global Allergy Immunotherapy Market, Size, Share, Analysis Report & Forecast to 2025 Request a Free Sample of our Report on Global Allergy Immunotherapy Market: https://www.omrglobal.com/request-sample/allergy-immunotherapy-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

  2. The global allergy immunotherapy market is expected to show a significant growth rate during the forecast period. Allergy is hypersensitive to the body’s immune system towards several substances that include pollen, dust, and food. There are various types of allergies includes drugs, food, pollen, latex, and dust among others. As per the Food Allergy Research & Association (FARA), around 15 million people in the US have food allergies and approximately 4% of which is seen in the pediatrics and around more than 60% in adults. The introduction of new immunotherapy drugs and advancement in the treatment and medicine of allergyis the factor fueling the growth of the allergy immunotherapy market during the forecast period. Request a Free Sample of Our Report on Global Allergy Immunotherapy Market: https://www.omrglobal.com/request-sample/allergy-immunotherapy-market The rising prevalence of allergies along with growing demand for the treatment of these diseases are motivating the key players of the allergy immunotherapy market to launch technologically advanced and cost-efficient treatment that can be affordable to the large pool of patients. The major market players are actively conducting strategic acquisitions, partnerships, and collaboration to increase their market presence and to gain a competitive edge. For instance, in April 2018, ALK had announced its partnership with Torii Pharmaceutical Co. Ltd. has agreed on a price with authorities and secured a listing on National health Insurance reimbursement for its sublingual allergy immunotherapy tablet against Japanese cedar allergy, brand name CEDAARCURE. A https://www.omrglobal.com/industry-reports/allergy-immunotherapy-market Full Report of Global Allergy Immunotherapy Market is Available at: In January 2019, Sandoz, Inc. had announced the introduction of SYMJEPI (epinephrine) 0.3 mg injection for the treatment of allergic reactions (Type 1) in the emergency including anaphylaxis, allergen immunotherapy, drugs, diagnostics testing substance, foods as well as exercise-induced anaphylaxis. The company is introducing this medicine as areasonable, affordable, single-dose and prefilled syringe alternative to epinephrine auto-injectors. In February 2018, Aimmune therapeutics, Biopharmaceutical Company developing a treatment for food allergies, introduced its phase 3 European clinical trial of AR101 for the treatment of peanut allergy that named ARTEMIS met its efficacy endpoint required by the Food and Drug Administration (FDA). Current Market Trends Covered in the Market Report •Growing cases of allergies across the globe •North America held the largest market share. •Product launch is a key focus of major market players to remain competitive in the market. •Improving healthcare infrastructure in the emerging economies across the globe. Global Allergy Immunotherapy Market- Segmentation

  3. By Type •Allergic Rhinitis •Allergic Asthma •Food Allergy •Drug Allergy •Others By Treatment •Subcutaneous Immunotherapy •Sublingual Immunotherapy By Distribution Channel •Hospital Pharmacy •Retail Pharmacy •Online Pharmacy Global Allergy Immunotherapy Market – Segment by Region North America •US •Canada Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World

  4. •Latin America •Middle East Africa For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/allergy-immunotherapy-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related